Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Clinical trial NCT05064280 · RECRUITING
Trial details
- NCT number
- NCT05064280
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2028-02-28
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.